Laffer Tengler Investments Amgen Inc Transaction History

Laffer Tengler Investments

$494 Billion
Q3 2024

A detailed history of Laffer Tengler Investments transactions in Amgen Inc stock. As of the latest transaction made, Laffer Tengler Investments holds 2,813 shares of AMGN stock, worth $729,410. This represents 0.18% of its overall portfolio holdings.

Number of Shares

2,813

Previous 2,758 1.99%

Holding current value

$729,410

Previous $862 Million 5.17%

% of portfolio

0.18%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $17,015 - $18,555	55 Added 1.99%	2,813 $906 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $17,604 - $21,393	67 Added 2.49%	2,758 $862 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $228,001 - $275,226	848 Added 46.01%	2,691 $765 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $14,574 - $16,442	-57 Reduced 3.0%	1,843 $531 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $160,051 - $198,708	732 Added 62.67%	1,900 $511 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2,999 - $3,547	-14 Reduced 1.18%	1,168 $259 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $6,096 - $7,430	27 Added 2.34%	1,182 $286 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $117,721 - $149,579	-514 Reduced 30.8%	1,155 $303 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $438 - $485	2 Added 0.12%	1,669 $404 Million
Q3 2021 Nov 16, 2021	SELL	$212.27 - $248.7 $353,005 - $413,588	-1,663 Reduced 49.94%	1,667 $354 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $1.86 Million - $2.07 Million	-7,975 Reduced 70.54%	3,330 $812 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $177,084 - $206,362	798 Added 7.59%	11,305 $2.81 Billion
Q4 2020 Jun 11, 2021	BUY	$216.38 - $257.67 $223,304 - $265,915	1,032 Added 10.89%	10,507 $2.39 Billion
Q4 2020 Feb 19, 2021	SELL	$216.38 - $257.67 $115,114 - $137,080	-532 Reduced 5.32%	9,475 $2.18 Billion
Q3 2020 Jun 11, 2021	BUY	$234.65 - $260.95 $3,285 - $3,653	14 Added 0.14%	10,007 $2.54 Billion
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $112,632 - $125,256	-480 Reduced 4.58%	9,993 $2.54 Billion
Q2 2020 Jun 11, 2021	BUY	$197.81 - $242.74 $129,565 - $158,994	655 Added 6.67%	10,473 $2.47 Billion
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $19,978 - $24,516	101 Added 1.04%	9,818 $2.32 Billion
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $133,217 - $176,682	731 Added 8.13%	9,717 $1.97 Billion
Q4 2019 Feb 20, 2020	BUY	$189.21 - $243.2 $990,703 - $1.27 Million	5,236 Added 139.63%	8,986 $2.17 Billion
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $3,482 - $4,172	-20 Reduced 0.53%	3,750 $726 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $3.33 Million - $3.9 Million	-19,955 Reduced 84.11%	3,770 $695 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $16,278 - $18,349	-90 Reduced 0.38%	23,725 $4.51 Billion
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $7,136 - $8,330	-40 Reduced 0.17%	23,815 $4.64 Billion
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $39,281 - $44,284	-212 Reduced 0.88%	23,855 $4.94 Billion
Q2 2018 Aug 16, 2018	SELL	$166.05 - $186.51 $19,926 - $22,381	-120 Reduced 0.5%	24,067 $4.44 Billion
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $3.4 Million - $3.97 Million	20,043 Added 483.66%	24,187 $4.12 Billion
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $262,468 - $293,257	1,555 Added 60.06%	4,144 $721 Million
Q3 2017 Nov 16, 2017	BUY	$167.29 - $191.0 $433,113 - $494,499	2,589	2,589 $483 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

News

Stay updated on Laffer Tengler Investments with notifications on news.

Account

Laffer Tengler Investments Amgen Inc Transaction History